Brief: Celyad Updates On Cyad-01
17/06/2019 06:32
June 17 (Reuters) - Celyad SA CYAD.BR :
* CELYAD PRESENTS CLINICAL UPDATE FOR CYAD-01 AT 24TH CONGRESS OF THE
EUROPEAN
HEMATOLOGY ASSOCIATION
* PRELIMINARY DATA FROM COHORT 10 OF THINK TRIAL EVALUATING DENSER SCHEDULE
OF
INFUSIONS OF CYAD-01 WITHOUT PRECONDITIONING SHOWED BETTER CELL ENGRAFTMENT
COMPARED TO BIWEEKLY INJECTIONS OF CYAD-01 WITHOUT PRECONDITIONING
* RESULTS FROM ONGOING PHASE 1 THINK AND DEPLETHINK TRIALS EVALUATING
CYAD-01
CONTINUE TO SUPPORT THERAPEUTIC CLINICAL DEVELOPMENT OF NKG2D-BASED CAR-T
THERAPY PRODUCT CANDIDATE
Source text for Eikon: ID:nNDL1XMDQb
Further company coverage: CYAD.BR
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))